Paragon 28 Drives Growth with New Product Cadence

Paragon 28 reported 2Q22 orthopedic sales of $42.5 million, +18.9% compared to 2Q21.

The company experienced modest COVID disruptions to procedure volume, but offset those via increased revenue contributions from newly launched products. The new products drove an 17% increase in salesforce productivity, defined by the company as the average...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us